ASH 2022 Conference Coverage
ASH 2022 Phase II DEDALO Trial: Daratumumab + Pomalidomide & Dexamethasone (DPd) in Patients With R/R MM and 17p Deletion
By
ASH 2022 Conference Coverage
FEATURING
Vittorio Montefusco
By
ASH 2022 Conference Coverage
FEATURING
Vittorio Montefusco
Login to view comments.
Click here to Login